Sanofi and Regeneron's Dupixent Gets More Positive Feedback From U.S. FDA Sanofi and Regeneron's Dupixent Gets More Positive Feedback From U.S. FDA

The U.S. Food& Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.Reuters Health Information (Source: Medscape Allergy Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2REpuSS